Concord Healthcare Group Co., Ltd. (HKG:2453)

Hong Kong · Delayed Price · Currency is HKD

0.8500

+0.0350 (4.29%)

Aug 12, 2026, 3:51 PM HKT

-84.98% (1Y)

Market Cap	638.68M -85.6%
Revenue (ttm)	511.81M +18.4%
Net Income	-285.55M
EPS	-0.38
Shares Out	783.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	683,400
Open	0.8400
Previous Close	0.8150
Day's Range	0.8150 - 0.8800
52-Week Range	0.6300 - 6.3800
Beta	-0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company offers oncology-related services, including sale and installation of medical equipment and software; and management and technical support services to hospitals and radiotherapy centers. It also engages in leasing radiotherapy and diagnostic imaging equipment; trading of r... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2008

Employees 592

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2453

Full Company Profile

Financial Performance

In 2025, Concord Healthcare Group's revenue was 459.92 million, an increase of 18.44% compared to the previous year's 388.31 million. Losses were -256.60 million, -42.11% less than in 2024.

Financial numbers in CNY Financial Statements